IL-10 and IL-10 receptor defects in humans

被引：193
|
作者：
Glocker, Erik-Oliver [1 ]
Kotlarz, Daniel [2 ]
Klein, Christoph [2 ]
Shah, Neil [3 ]
Grimbacher, Bodo [4 ,5 ]
机构：
[1] Univ Hosp Freiburg, Inst Med Microbiol & Hyg, Freiburg, Germany
[2] Univ Munich, Dr von Hauner Childrens Hosp, Dept Pediat, Munich, Germany
[3] UCL, Great Ormond St Hosp, Dept Paediat Gastroenterol, London, England
[4] UCL, Sch Med, Dept Immunol, London W1N 8AA, England
[5] Univ Hosp Freiburg, Ctr Chron Immune Deficiency, Freiburg, Germany
来源：
YEAR IN HUMAN AND MEDICAL GENETICS: INBORN ERRORS OF IMMUNITY II | 2011年 / 1246卷
关键词：
IL-10; receptor; mutation; STAT3; inflammatory bowel disease; INFLAMMATORY-BOWEL-DISEASE; REGULATORY T-CELLS; X-LINKED SYNDROME; INTERLEUKIN-10; RECEPTOR; IMMUNE DYSREGULATION; ULCERATIVE-COLITIS; EPITHELIAL-CELLS; CROHNS-DISEASE; HOST-DEFENSE; POLYENDOCRINOPATHY;
D O I：
10.1111/j.1749-6632.2011.06339.x
中图分类号：
Q3 [遗传学];
学科分类号：
071007 ; 090102 ;
摘要：
Inflammatory bowel disease (IBD), which includes Crohn's disease (CD) and ulcerative colitis (UC), is chronic in nature and is characterized by abdominal pain, diarrhea, bleeding, and malabsorption. It is considered a complex multigenic and multifactorial disorder that results from disturbed interactions between the immune system and commensal bacteria of the gut. Recent work has demonstrated that IBD with an early-onset within the first months of life can be monogenic: mutations in IL-10 or its receptor lead to a loss of IL-10 function and cause severe intractable enterocolitis in infants and small children. Both IL-10 and IL-10 receptor deficiency can be successfully treated by hematopoietic stem cell transplantation.
引用
收藏
页码：102 / 107
页数：6
相关论文
共 50 条
  • [1] IL-10 in Humans: Lessons from the Gut, IL-10/IL-10 Receptor Deficiencies, and IL-10 Polymorphisms
    Engelhardt, Karin R.
    Grimbacher, Bodo
    INTERLEUKIN-10 IN HEALTH AND DISEASE, 2014, 380 : 1 - 18
  • [2] IL-10 or not IL-10: that is the question
    Dragana Jankovic
    Giorgio Trinchieri
    Nature Immunology, 2007, 8 : 1281 - 1283
  • [3] IL-10 or not IL-10: that is the question
    Jankovic, Dragana
    Trinchieri, Giorgio
    NATURE IMMUNOLOGY, 2007, 8 (12) : 1281 - 1283
  • [4] ELEVATED IL-10 LEVEL IN A PATIENT WITH IL-10 RECEPTOR DEFICIENCY
    LaBarba, S.
    Bonagura, V.
    Jongco, A.
    Sahn, B.
    Lim, C. E.
    Glocker, E.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2015, 115 (05) : A87 - A87
  • [5] IL-10 and IL-10 receptor overexpression in oral giant cell lesions
    Syrio, Narriman-Fatima-Lima
    Faria, Daniela-Rodrigues
    Gomez, Ricardo-Santiago
    Gollob, Kenneth-John
    Dutra, Walderez-Ornelas
    Souza, Paulo-Eduardo-Alencar
    MEDICINA ORAL PATOLOGIA ORAL Y CIRUGIA BUCAL, 2011, 16 (04): : E488 - E492
  • [6] Binding of IL-10 to epithelial cells is independent of IL-10 receptor 1 expression
    Kraus, T
    Panja, A
    Mayer, L
    FASEB JOURNAL, 2000, 14 (06): : A1082 - A1082
  • [7] The EBV IL-10 homologue is a selective agonist with impaired binding to the IL-10 receptor
    Liu, Y
    Malefyt, RD
    Briere, F
    Parham, C
    Bridon, JM
    Banchereau, J
    Moore, KW
    Xu, JC
    JOURNAL OF IMMUNOLOGY, 1997, 158 (02): : 604 - 613
  • [8] Interleukin-10 (IL-10) in experimental visceral leishmaniasis and IL-10 receptor blockade as immunotherapy
    Murray, HW
    Lu, CM
    Mauze, S
    Freeman, S
    Moreira, AL
    Kaplan, G
    Coffman, RL
    INFECTION AND IMMUNITY, 2002, 70 (11) : 6284 - 6293
  • [9] IL-10 RECEPTOR (IL-10R) TRANSFECTANTS RESPONSES TO VIRAL IL-10 - EVIDENCE FOR ADDITIONAL IL-10R COMPONENTS
    XUAMANO, JC
    LIU, Y
    WEI, SHY
    HO, ASY
    HSU, AKH
    MOORE, KW
    FASEB JOURNAL, 1995, 9 (04): : A772 - A772
  • [10] PEDF binds to IL-10 receptor in the absence of IL-10 and inhibits melanoma tumor growth
    Khan, Aslam A.
    CANCER RESEARCH, 2012, 72
12345